Because of a lapse in government funding, the information on this website may not be up to date, transactions submitted via the website may not be processed, and the agency may not be able to respond to inquiries until appropriations are enacted. The NIH Clinical Center (the research hospital of NIH) is open. For more details about its operating status, please visit cc.nih.gov. Updates regarding government operating status and resumption of normal operations can be found at opm.gov.

NLM Logo

SR 140333 MeSH Supplementary Concept Data 2025


MeSH Supplementary
SR 140333
Unique ID
C085215
RDF Unique Identifier
http://id.nlm.nih.gov/mesh/C085215
Entry Term(s)
1-(2-(3-(3,4-dichlorophenyl)-1-(3-isopropoxyphenylacetyl)piperidin-3-yl)ethyl)-4-phenyl-1-azabicyclo(2.2.2)octane chloride
SR 140,333
SR 140603
SR-140,333
SR-140333
SR-140603
SR140,333
SR140333
Registry Numbers
153050-21-6
CAS Type 1 Name
1-Azoniabicyclo(2.2.2)octane, 1-(2-(3-(3,4-dichlorophenyl)-1-((3-(1-methylethoxy)phenyl)acetyl)-3-piperidinyl)ethyl)-4-phenyl-, chloride, (S)-
Heading Mapped to
*Piperidines
*Quinuclidines
Frequency
236
Note
SR-140603 is the (R)-antipode of SR-140333; a neurokinin-1 receptor antagonist
Source
FEBS Lett 1993 Dec 28;336(3):506-10
Indexing Information
Stereoisomerism
Date of Entry
1994/02/08
Revision Date
2016/03/14
SR 140333 Preferred
1-(2-(3-(3,4-dichlorophenyl)-1-(3-isopropoxyphenylacetyl)piperidin-3-yl)ethyl)-4-phenyl-1-azabicyclo(2.2.2)octane chloride Broader
SR 140603 Related
page delivered in 0.006s